Ahead-of-Print
Review
-
From liberal to restrictive and beyond: a narrative review of red blood cell transfusion strategies in the modern era: Restrictive transfusion strategies: a narrative review
-
Regional implementation, guideline landscape, and economic impact of blood component leukoreduction: a systematic literature review: Systematic literature review on leukoreduction
-
Homocysteine as a risk factor for thrombosis and when to ask for testing: Homocysteine and thrombosis
-
Perioperative hemostatic therapy in adult cardiac surgery: a narrative review highlighting human factors: A narrative review highlighting human factors
Original article
-
The 2 breakpoint regions of an RHCE-D(2-9)-CE allele causing a D-- phenotype and its RhAG antigen density: RHCE-D(2-9)-CE hybrid allele and RhAG density
-
Toward clinical use of allogeneic red cell concentrates from umbilical cord blood: feasibility and process optimization: Feasibility of cord blood red cell concentrate production
-
Perceived risk explains aversion to blood donation by men who have sex with men: Risk, aversion, and blood donated by MSM
-
Predicting citrate-related reactions in plateletpheresis donors: development and temporal validation of a prognostic score: Citrate reactions in plateletpheresis donors
-
Distribution of human platelet antigen genotypes in Lithuanian blood donors: HPA genotypes in Lithuanian donors
-
IgA driven autoimmune hemolytic anemia: a monocentric Italian report and literature review: Management of IgA mediated AIHA
-
Results of red cell antibody screening assays from 2,500 laboratories in 10 external quality assessment programs: sensitivity for anti-D: Sensitivity of red cell antibody detection
-
Beyond the operating room: preservation of blood quality and erythrocyte function in postoperative salvaged mediastinal blood: Postoperative salvaged mediastinal blood
-
Establishment of a high-resolution melting assay for detection of GYP*Mur allele zygosity: HRM assay for GYP*Mur zygosity
-
Donor-wise metabolomic prediction of platelet storage duration: a proof-of-concept study: Donor-wise metabolomic prediction in platelets
Case report
-
Concurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report: Treating AvWS and CLL with Acalabrutinib
-
Eptacog beta for breakthrough elbow hemarthrosis during concizumab prophylaxis in a pediatric patient with hemophilia B: a case report: Episodic eptacog-beta treatment in concizumab prophylaxis
-
Navigating boundaries of autoimmunity in rare anemias: anti-erythropoietin antibody-mediated pure red cell aplasia in a patient with cold agglutinin disease: Anti-EPO pure red cell aplasia in cold agglutinin disease
-
Peripartum management of a monochorionic diamniotic twin pregnancy in a woman with mild hemophilia B using eftrenonacog alfa: a case report: A safe delivery in a high-risk setting
Letter to the Editor
-
Atypical syncope during plasma donation as the first manifestation of an obstructive hydrocephalus: Donor reaction reveals hydrocephalus
-
Patient Blood Management in the Emergency Department: reducing transfusions and anemia-related admissions at 6 months: PBM in Emergency Departments: 6-month impact
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more